SCHEMBL30342140

SCHEMBL30342140

Fc1ccc([Mg]Br)c(F)c1Cl

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.32
RIPK1 Q13546 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1446076 0.78 CES2 (0.36)
SCHEMBL1445753 0.74 CES2 (0.30)
SCHEMBL38662699 0.73 HDAC4 (0.30)
SCHEMBL31444326 0.73 TAAR1 (0.32)
SCHEMBL1863530 0.73 TAAR1 (0.32)
SCHEMBL31289362 0.72 TNF (0.41) TNFRIPK1
SCHEMBL2046247 0.72 TNF (0.41) TNFRIPK1
SCHEMBL1003501 0.69 TNF (0.35) TNFRIPK1
SCHEMBL29414007 0.69 TNF (0.35) TNFRIPK1
SCHEMBL4659546 0.68 SLC6A4 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117881664-A Cycloalkyl 3-oxopiperazine carboxamides and cycloheteroalkyl 3-oxopiperazine carboxamides as NAV1.8 inhibitors 默沙东有限责任公司 2024-04-12 CN disclosed
CN-116134018-A 2-oxoimidazolidine-4-carboxamide as NAV1.8 inhibitor 默沙东有限责任公司 2023-05-16 CN disclosed
EP-4168393-A1 2-OXOIMIDAZOLIDINE-4-CARBOXAMIDES AS NAV1.8 INHIBITORS Merck Sharp & Dohme LLC (US) 2023-04-26 EP disclosed